161 related articles for article (PubMed ID: 12558609)
21. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
Patel M; Thomson NC
Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model.
Henderson WR; Banerjee ER; Chi EY
J Allergy Clin Immunol; 2005 Aug; 116(2):332-40. PubMed ID: 16083788
[TBL] [Abstract][Full Text] [Related]
23. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
Lee DK; Jackson CM; Bates CE; Lipworth BJ
Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
[TBL] [Abstract][Full Text] [Related]
24. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.
van Schayck CP; Graafsma SJ; Visch MB; Dompeling E; van Weel C; van Herwaarden CL
J Allergy Clin Immunol; 1990 Nov; 86(5):793-800. PubMed ID: 1977787
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers.
Schmekel B; Rydberg I; Norlander B; Sjöswärd KN; Ahlner J; Andersson RG
Eur Respir J; 1999 Jun; 13(6):1230-5. PubMed ID: 10445595
[TBL] [Abstract][Full Text] [Related]
26. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
[TBL] [Abstract][Full Text] [Related]
27. Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
Jacobson GA; Raidal S; Hostrup M; Calzetta L; Wood-Baker R; Farber MO; Page CP; Walters EH
Drug Saf; 2018 May; 41(5):441-449. PubMed ID: 29332144
[TBL] [Abstract][Full Text] [Related]
28. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
29. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
30. Bronchial hyperresponsiveness induced by chronic treatment with albuterol: Role of sensory nerves.
Keir S; Page C; Spina D
J Allergy Clin Immunol; 2002 Sep; 110(3):388-94. PubMed ID: 12209084
[TBL] [Abstract][Full Text] [Related]
31. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
32. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma.
Matsumoto K; Aizawa H; Fukuyama S; Yoshida M; Komori M; Takata S; Koto H; Inoue H
Respir Investig; 2013 Sep; 51(3):158-65. PubMed ID: 23978642
[TBL] [Abstract][Full Text] [Related]
33. Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone.
Groeben H; Silvanus MT; Beste M; Peters J
Anesthesiology; 1998 Oct; 89(4):862-8. PubMed ID: 9778003
[TBL] [Abstract][Full Text] [Related]
34. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
Handley D
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
[TBL] [Abstract][Full Text] [Related]
36. Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children.
Jartti TT; Kaila TJ; Tahvanainen KU; Kuusela TA; Vanto TT; Välimäki IA
Eur J Pediatr; 1997 Nov; 156(11):883-8. PubMed ID: 9392406
[TBL] [Abstract][Full Text] [Related]
37. Albuterol enantiomers: pre-clinical and clinical value?
Ameredes BT; Calhoun WJ
Front Biosci (Elite Ed); 2010 Jun; 2(3):1081-92. PubMed ID: 20515778
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo.
Baldwin DR; Sivardeen Z; Pavord ID; Knox AJ
Thorax; 1994 Nov; 49(11):1103-8. PubMed ID: 7831625
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.
Fogli S; Stefanelli F; Martelli A; Daniele S; Testai L; Calderone V; Trincavelli ML; Martini C; Breschi MC
Pulm Pharmacol Ther; 2013 Dec; 26(6):693-9. PubMed ID: 23810957
[TBL] [Abstract][Full Text] [Related]
40. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
